Drawing for COHERUS

USPTO serial 90858291

COHERUS

Reviewed by CopyMark Law Group

Reg. 6921362Status 700Registered
Filing date
Status date
Registration date
Dec 13, 2022
Examiner
FATHY, DOMINIC
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with COHERUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Perry J. Viscounty

Perry J. Viscounty LATHAM & WATKINS LLP650 TOWN CENTER DRIVE, SUITE 2000COSTA MESA, CA 92626UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceuticals for human immune diseases and conditions; pharmaceuticals for use in stimulating white blood cell production; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of inflammation; Pharmaceuticals for the treatment of cancer, autoimmune diseases, metabolic diseases, or ophthalmic diseases and conditions; Pharmaceutical preparations for the prevention and treatment of auto-immune, inflammatory, hematological, hepatological, cardiovascular, pulmonary, central nervous system, neurological system, pain, inflammation, dermatologic, gastro-intestinal, hormonal, psychiatric, infectious-related, viral, metabolic, oncologic, ophthalmic, respiratory, digital ulcers, musculo-skeletal, genitourinary, sexual dysfunction, and cerebrovascular diseases and disorders; vaccines; anxiolytics; anti-allergics; anti-infectives; pharmaceutical preparations for treatment of ocular diseases and disorders; pharmaceuticals for the treatment of oncology, immunology, ophthalmology diseases and disordersACTIVEJan 13, 2019
042research, development and consulting services in the pharmaceutical research and biotechnology fields; consulting, research and development in the medical fieldACTIVEMay 10, 2012
044providing information in the fields of health and medicine; consulting services in the field of pharmaceuticals and medical careACTIVEMay 10, 2012

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 9, 2026ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Aug 21, 2025ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
May 16, 2024ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Dec 13, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 13, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 27, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 27, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 7, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 24, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 23, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 22, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 22, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 22, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 22, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 22, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 22, 2022DOCKASSIGNED TO EXAMINER—
Sep 27, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 3, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance